A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.

@article{Pambianco2016API,
  title={A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.},
  author={Daniel J. Pambianco and Keith M. Borkett and Dennis S. Riff and Peter J. Winkle and Howard I. Schwartz and Timothy I Melson and Karin Wilhelm-Ogunbiyi},
  journal={Gastrointestinal endoscopy},
  year={2016},
  volume={83 5},
  pages={
          984-92
        }
}
BACKGROUND AND AIMS Remimazolam is an ultra-short-acting benzodiazepine currently being developed for procedural sedation and for induction and maintenance of anesthesia. This trial was the fourth study for procedural sedation. The aim was to compare the safety and efficacy profile of remimazolam and to refine suitable doses for subsequent phase III studies in this indication. METHODS This was a randomized, double-blind, parallel group, active controlled clinical trial with 162 male and… CONTINUE READING
BETA

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Remimazolam: new beginnings or just a me-too?

  • Anesthesia and analgesia
  • 2012
VIEW 2 EXCERPTS